Feasibility of Xpert Ebola assay in médecins sans Frontières Ebola program, Guinea

Emerging Infectious Diseases

Volumn 22, Issue 2, 2016, Pages 210-216

  Van Den Bergh, Rafael ^a   Chaillet, Pascale ^a   Sow, Mamadou Saliou ^b,c   Amand, Mathieu ^d   Van Vyve, Charlotte ^d   Jonckheere, Sylvie ^d   Crestani, Rosa ^a   Sprecher, Armand ^a   Van Herp, Michel ^a   Chua, Arlene ^d,e   Piriou, Erwan ^d   Koivogui, Lamine ^f   Antierens, Annick ^a  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

^b Hôpital National Donka   (Equatorial Guinea)

^c Comité de Recherche Ebola de Guinée ^*  (Equatorial Guinea)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e Clinical Epidemiology   (Singapore)

^f Institut National de Santé Publique   (Equatorial Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CROSS-SECTIONAL STUDY; EBOLA HEMORRHAGIC FEVER; EPIDEMIOLOGICAL MONITORING; FEMALE; GUINEA; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRESCHOOL CHILD; RAPID TEST; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TRANSFUSION; VIRUS LOAD; EBOLAVIRUS; GENETICS; HEMORRHAGIC FEVER, EBOLA; MOLECULAR TYPING; PROCEDURES; REPRODUCIBILITY; STANDARDS; VERY ELDERLY; VIROLOGY; VIRUS GENE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EBOLAVIRUS; FEMALE; GENES, VIRAL; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84955144664     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2202.151238     Document Type: Article

References (11)

1. World Health Organization. Ebola situation report—June 28, 2015. Geneva: The Organization; 2015.
2. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371:2092-100. http://dx.doi.org/10.1056/NEJMoa1411680
3. World Health Organization. Policy statement. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/ RIF system. Geneva: The Organization; 2011.
4. Hamburg MA. Authorization of the emergency use of the Xpert Ebola Assay, US Food and Drug Administration; 2015 [cited 2015 Nov 10]. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM439583.pdf
5. World Health Organization. WHO emergency use assessment and listing for EVD IVDs: Xpert Ebola Assay. Geneva: The Organization; 2015.
6. Mohammadi D. First trials for Ebola treatments announced. Lancet. 2014;384:1833. http://dx.doi.org/10.1016/S0140-6736(14)62043-2
7. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372:40-7. http://dx.doi.org/10.1056/NEJMoa1411249
8. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, et al. ReEBOV antigen rapid test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386:867-74. http://dx.doi.org/10.1016/S0140-6736(15)61042-X
9. Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, et al. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, western area, Sierra Leone, January to February 2015. Euro Surveill. 2015;20:pii: 21073.
10. Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014;383:424-35. http://dx.doi.org/10.1016/S0140-6736(13)62073-5
11. Raizada N, Sachdeva KS, Sreenivas A, Vadera B, Gupta RS, Parmar M, et al. Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. PLoS ONE. 2014;9:e89301. http://dx.doi.org/10.1371/journal.pone.0089301